First Albany Capital

First Albany Capital was a prominent American investment bank and brokerage firm that served as a key financial architect for the emerging biotechnology and healthcare sectors. Founded in 1953 and headquartered in Albany, New York, the firm established a formidable reputation for its specialized equity research and investment banking services tailored to life sciences companies. Throughout the 1990s and early 2000s, First Albany was instrumental in managing initial public offerings and providing strategic advisory for numerous innovative biotech and medical technology firms. The company eventually transitioned through a series of corporate restructurings, rebranding as Broadpoint Securities Group in 2007 and later becoming part of Gleacher & Company. Its legacy remains tied to its role in fueling the capital requirements of the early modern biotech industry.